Core Laboratories Inc. CLB is set to release third-quarter earnings on Oct. 23, after the closing bell. The Zacks Consensus Estimate for profit in the to-be-reported quarter is pegged at 25 cents per ...

In the current session, Core Laboratories Inc. (NYSE:CLB) is trading at $14.95, after a 0.60% drop. Over the past month, the stock decreased by 6.33%, and in the past year, by 26.54%. With performance ...

Core Laboratories (NYSE:CLB) reported fourth-quarter and full-year 2025 results that reflected modest top-line growth, continued shareholder returns, and a mix of strength in international demand ...

HOUSTON, Oct. 9, 2023 /PRNewswire/ -- Halliburton Company (HAL) and Core Laboratories Inc. (NYSE: CLB) today announced a strategic collaboration in the U.S. to compress the delivery time of ...

CEO Lawrence V. Bruno highlighted that "Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic ...

Wide-moat Core Laboratories posted third-quarter results mostly in line with our estimates. Revenue of $134 million was up 3% sequentially and 7% year over year, while operating income of $20 million ...

Ariel Investments, an investment management company, released its “Ariel Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter was a volatile ...

Core Laboratories Inc. CLB reported third-quarter 2025 adjusted earnings of 22 cents per share, which beat the Zacks Consensus Estimate of 19 cents. This can be attributed to the outperformance of the ...

Core Laboratories is the premiere provider of reservoir characterization services. Its foundational core analysis business has been virtually untouched over the last several decades, and the firm has ...